Rubella Susceptibility in Multiparous Women

Rubella Clinical Trial

Official title:

Rubella Susceptibility in Multiparous Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00401505
• Other study ID #: 06-186
• Status: Completed
• Start date: September 2006
• Est. completion date: September 2012

Study information

• Verified date: February 2019
• Source: St. Michael's Hospital, Toronto
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine the reasons why multiparous women (women who are pregnant and have been pregnant before) might still be susceptible to rubella.

Description:

This study is designed to investigate why multiparous women might still be susceptible to rubella. All pregnant women are checked for rubella immunity, and if they are non-immune, there are standard orders in our hospital to administer the rubella vaccine on the post-partum floor prior to discharge home from the hospital. Despite this, some multiparous women are found to be susceptible (non-immune), and this study will explore the reasons for this.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 310
• Est. completion date: September 2012
• Est. primary completion date: September 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• All rubella susceptible women who delivered during the study period.

Related Conditions & MeSH terms

• Disease Susceptibility
• Rubella
• Vaccine

Locations

Country	Name	City	State
Canada	St. Michael's Hospital	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada,